1.Leclercq, R and Coignard, B (2006) Les entérocoques résistants aux glycopeptides: situation en France en 2005. Bulletin Epidémiologique Hebdomadaire 13, 85–87.
2.Henard, S et al. (2011) Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004–2009. International Journal of Hygiene and Environmental Health 214, 265–270.
3.Bourdon, N, Fines, M and Leclercq, R (2008) Caractéristiques des souches d'entérocoques résistants aux glycopeptides isolées en France, 2006–2008. Bulletin Epidémiologique Hebdomadaire 41–42, 391–394.
4.Stockholm: ECDC (2015) European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net).
5.Hautemanière, A et al. (2009) A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant enterococci on mortality during a hospital outbreak. American Journal of Infection Control 37, 746–752.
6.Salgado, CD and Farr, BM (2003) Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infection Control and Hospital Epidemiology 24, 690–698.
7.Hoshuyama, T et al. (2008) Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies. Journal of Infection and Chemotherapy 14, 354–360.
8.Correa, AAF et al. (2015) Small hospitals matter: insights from the emergence and spread of vancomycin-resistant enterococci in 2 public hospitals in inner Brazil. Diagnostic Microbiology and Infectious Disease 82, 227–233.
9.Martínez, JA et al. (2003) Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Archives of Internal Medicine 163, 1905–1912.
10.McEvoy, SP et al. (2006) Risk factors for the acquisition of vancomycin-resistant enterococci during a single-strain outbreak at a major Australian teaching hospital. Journal of Hospital Infection 62, 256–258.
11.MacIntyre, CR et al. (2001) Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infection Control and Hospital Epidemiology 22, 624–629.
12.Sakka, V et al. (2008) Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clinical Microbiology and Infection 14, 14–21.
13.Servais, A et al. (2009) Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department. Clinical Journal of the American Society of Nephrology 4, 1559–1564.
14.Assadian, O et al. (2007) Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran. BMC Infectious Diseases 7, 52.
15.Karki, S et al. (2012) Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrobial Resistance and Infection Control 1, 31.
16.Roghmann, M et al. (1998) Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients. American Journal of Kidney Diseases 32, 254–257.
17.Fossi Djembi, L et al. (2017) Factors associated with vancomycin-resistant Enterococcus acquisition during a large outbreak. Journal of Infection and Public Health 10, 185–190.
18.Amberpet, R et al. (2016) Screening for intestinal colonization with vancomycin resistant enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital. Journal of Clinical and Diagnostic Research 10, DC06–DC09.
19.Monteserin, N and Larson, E (2016) Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. Journal of Hospital Infection 94, 236–241.
20.Instruction DGOS/PF2/DGS/RI1 n°2014-08 du 14 janvier 2014 relative aux recommandations pour la prévention de la transmission croisée des bactéries hautement résistantes aux antibiotiques émergentes.
21.Ury, HK (1975) Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data. Biometrics 31, 643–649.
22.Gelman, A et al. (2013) Bayesian Data Analysis, 3rd Edn. Boca Raton: Chapman and Hall/CRC.
23.Hoff, PD (2009) A First Course in Bayesian Statistical Methods. New York, NY: Springer New York.
24.Gilbert, EM et al. (2017) Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption. Diagnostic Microbiology and Infectious Disease 89, 72–77.
25.Cetinkaya, Y, Falk, PS and Mayhall, CG (2002) Effect of gastrointestinal bleeding and oral medications on acquisition of vancomycin-resistant Enterococcus faecium in hospitalized patients. Clinical Infectious Diseases 35, 935–942.
26.Byers, KE et al. (2001) A hospital epidemic of vancomycin-resistant enterococcus: risk factors and control. Infection Control of Hospital Epidemiology 22, 140–147.